Items where authors include "Griffiths, CEM"

Article

Loeff, FC, Tsakok, T, Dijk, L et al. (19 more authors) (2020) Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter Study. Journal of Investigative Dermatology, 140 (11). pp. 2129-2137. ISSN 0022-202X

Mahil, SK, Wilson, N, Dand, N et al. (10 more authors) (2020) Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR). British Journal of Dermatology, 182 (5). pp. 1158-1166. ISSN 0007-0963

Tsakok, T, Wilson, N, Dand, N et al. (23 more authors) (2019) Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis. JAMA Dermatology, 155 (11). p. 1235. ISSN 2168-6068

Dand, N, Duckworth, M, Baudry, D et al. (24 more authors) (2019) HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis. Journal of Allergy and Clinical Immunology, 143 (6). pp. 2120-2130. ISSN 0091-6749

Warren, RB, Marsden, A, Tomenson, B et al. (8 more authors) (2019) Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study. British Journal of Dermatology, 180 (5). pp. 1069-1076. ISSN 0007-0963

Thorneloe, RJ orcid.org/0000-0002-7522-221X, Griffiths, CEM, Emsley, R et al. (2 more authors) (2018) Intentional and Unintentional Medication Non-Adherence in Psoriasis: The Role of Patients’ Medication Beliefs and Habit Strength. Journal of Investigative Dermatology, 138 (4). pp. 785-794. ISSN 0022-202X

Majeed-Ariss, R orcid.org/0000-0003-0892-4710, McPhee, M, Bundy, C et al. (2 more authors) (2018) Developing a protocol to identify and prioritize research questions for psoriasis: a James Lind Alliance Priority Setting Partnership. British Journal of Dermatology, 178 (6). pp. 1383-1387. ISSN 0007-0963

Keyworth, C orcid.org/0000-0002-7815-6174, Nelson, PA, Bundy, C et al. (3 more authors) (2018) Does message framing affect changes in behavioural intentions in people with psoriasis? A randomized exploratory study examining health risk communication. Psychology, Health and Medicine, 23 (7). pp. 763-778. ISSN 1354-8506

Thorneloe, RJ orcid.org/0000-0002-7522-221X, Griffiths, CEM, Ashcroft, DM et al. (1 more author) (2017) The challenges of assessing patients' medication beliefs: a qualitative study. BMC Health Services Research, 17. 119. ISSN 1472-6963

Nelson, PA, Kane, K, Pearce, CJ et al. (7 more authors) (2017) ‘New to me’: changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well ® patient materials mixed-methods feasibility study. British Journal of Dermatology, 177 (3). pp. 758-770. ISSN 0007-0963

Thorneloe, RJ orcid.org/0000-0002-7522-221X, Bundy, C, Griffiths, CEM et al. (2 more authors) (2017) Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis. British Journal of Dermatology, 176 (3). pp. 667-676. ISSN 0007-0963

Bowes, J, Eyre, S, Flynn, E et al. (17 more authors) (2011) Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Annals of the Rheumatic Diseases, 70 (6). pp. 1016-1019. ISSN 0003-4967

Conference or Workshop Item

Mahil, S, Wilson, N, Reynolds, NJ et al. (6 more authors) (2019) Defining outcomes in psoriasis using a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register): towards a treat-to-target approach. In: British Association of Dermatologists 99th Annual Meeting, 02-04 Jul 2019, Liverpool, UK.